Works matching IS 25233548 AND DT 2022 AND VI 42 AND IP 8
Results: 12
Cover Image, Volume 42, Issue 8.
- Published in:
- Cancer Communications, 2022, v. 42, n. 8, p. ii, doi. 10.1002/cac2.12355
- By:
- Publication type:
- Article
Cover Image, Volume 42, Issue 8.
- Published in:
- Cancer Communications, 2022, v. 42, n. 8, p. i, doi. 10.1002/cac2.12354
- By:
- Publication type:
- Article
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy.
- Published in:
- Cancer Communications, 2022, v. 42, n. 8, p. 683, doi. 10.1002/cac2.12340
- By:
- Publication type:
- Article
Intrinsic PD‐L1 promotes antitumor activity of CD8<sup>+</sup> cytotoxic T lymphocytes via in cis interaction with CD80.
- Published in:
- Cancer Communications, 2022, v. 42, n. 8, p. 784, doi. 10.1002/cac2.12337
- By:
- Publication type:
- Article
Snail acetylation by autophagy‐derived acetyl‐coenzyme A promotes invasion and metastasis of KRAS‐LKB1 co‐mutated lung cancer cells.
- Published in:
- Cancer Communications, 2022, v. 42, n. 8, p. 716, doi. 10.1002/cac2.12332
- By:
- Publication type:
- Article
Low cholesterol biosynthesis favors epithelial‐to‐mesenchymal transition maintenance and influences tumor molecular subtyping and disease‐free survival in colon cancer patients.
- Published in:
- Cancer Communications, 2022, v. 42, n. 8, p. 793, doi. 10.1002/cac2.12329
- By:
- Publication type:
- Article
Vitamin D<sub>3</sub> for reducing mortality from cancer and other outcomes before, during and beyond the COVID‐19 pandemic: A plea for harvesting low‐hanging fruit.
- Published in:
- Cancer Communications, 2022, v. 42, n. 8, p. 679, doi. 10.1002/cac2.12328
- By:
- Publication type:
- Article
DNA methylation signature predicts cancer response to demethylation agents from profiling diverse cancer cell lines.
- Published in:
- Cancer Communications, 2022, v. 42, n. 8, p. 789, doi. 10.1002/cac2.12326
- By:
- Publication type:
- Article
PDGFA‐associated protein 1 is a novel target of c‐Myc and contributes to colorectal cancer initiation and progression.
- Published in:
- Cancer Communications, 2022, v. 42, n. 8, p. 750, doi. 10.1002/cac2.12322
- By:
- Publication type:
- Article
The establishment of polypeptide PSMA‐targeted chimeric antigen receptor‐engineered natural killer cells for castration‐resistant prostate cancer and the induction of ferroptosis‐related cell death.
- Published in:
- Cancer Communications, 2022, v. 42, n. 8, p. 768, doi. 10.1002/cac2.12321
- By:
- Publication type:
- Article
Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
- Published in:
- Cancer Communications, 2022, v. 42, n. 8, p. 689, doi. 10.1002/cac2.12295
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Communications, 2022, v. 42, n. 8, p. 677, doi. 10.1002/cac2.12172
- Publication type:
- Article